The Competition Commission of India (CCI) has given the green light for TPG Growth V SF Markets Pte. Ltd. to acquire roughly 8% of API Holdings Private Limited. TPG Growth, a Singapore-based investment vehicle funded by TPG and the Korean Investment Corporation, will now hold a stake in API Holdings, the parent company of a group involved in drug distribution, e-commerce platforms for pharmaceuticals, and manufacturing of various health products.
The Competition Commission of India (CCI) approves acquisition by TPG Growth V SF Markets Pte. Ltd. (TPG/Acquirer) of 8% (approx.) of the equity shareholding of API Holdings Private Limited (API/Target) under Section 31(1) of the Competition Act, 2002, yesterday.
The Acquirer is a newly incorporated special purpose investment vehicle in Singapore and as on date, it does not have any physical presence and investments in India. The Acquirer would be jointly funded by TPG (i.e. TPG Global, LLC a
The CCI has approved the acquisition by TPG Growth V SF Markets Pte. Ltd. of approximately 8% of the equity shareholding of API Holdings Private Limited.
The acquirer is TPG Growth V SF Markets Pte. Ltd., a newly incorporated special purpose investment vehicle based in Singapore.
The acquirer is jointly funded by TPG (TPG Global, LLC and its affiliates) and the Korean Investment Corporation.
API Holdings is involved in the wholesale sale and distribution of drugs, provision of transportation services for the pharmaceutical sector, development of e-commerce platforms for pharmaceuticals, and manufacturing and marketing of pharmaceutical, ayurvedic, and nutraceutical products, among others.
As of the date of the approval, the acquirer does not have any physical presence and investments in India.
Finance news reporter covering taxation, GST, income tax, business compliance, and economy updates. I simplify complex financial topics into easy-to-understand articles for professionals, taxpayers, and business owners on leading finance and tax platforms.